MFAP2 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Activating TGF-β/SMAD2/3 Signaling Pathway [Retraction]
2026
Read MFAP2 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Activating TGF-β/SMAD2/3 Signaling Pathway [Retraction] (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13289763.txt.
Description
Editors and the publisher of OncoTargets and Therapy issued a 2026 retraction notice for a 2018 article on MFAP2 and gastric cancer by Wang and coauthors. A third party raised integrity concerns in 2025 about Figures 4 and 5. Journal checks found repeated unexpected similarities in cell invasion images within and across papers, plus Western blot overlaps said to show different proteins. The notice documents those overlaps in detail but adds no new findings, keeping its scope narrow.
Catalog record
| YEAR | 2026 |
|---|---|
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6140 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |